بدائل البحث:
significant effects » significant effect (توسيع البحث), significantly affected (توسيع البحث)
effects decrease » effects decreased (توسيع البحث), effects regress (توسيع البحث)
gap decrease » a decrease (توسيع البحث), gain decreased (توسيع البحث), step decrease (توسيع البحث)
significant effects » significant effect (توسيع البحث), significantly affected (توسيع البحث)
effects decrease » effects decreased (توسيع البحث), effects regress (توسيع البحث)
gap decrease » a decrease (توسيع البحث), gain decreased (توسيع البحث), step decrease (توسيع البحث)
-
61
-
62
-
63
-
64
-
65
Summary of post-treatment disease course measures from MDMA-AT publications.
منشور في 2025الموضوعات: -
66
-
67
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
منشور في 2025الموضوعات: -
68
-
69
-
70
-
71
Summary of post-treatment disease course measures from off-label medications clinical trials.
منشور في 2025الموضوعات: -
72
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
منشور في 2025الموضوعات: -
73
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
منشور في 2025الموضوعات: -
74
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
منشور في 2025الموضوعات: -
75
-
76
-
77
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
منشور في 2025الموضوعات: -
78
Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
79
Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
80
Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"